The conversation has shifted from when to stop the medication to whether stopping is the right approach for many patients
Physically active GLP-1 patients who need connective tissue and recovery support
These therapies mimic the action of the endogenous GLP-1 hormone to stimulate insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite, making them highly effective for the management of type 2 diabetes and chronic weight management
If you have a high deductible plan, unfortunately when youre inside insurance, if you actually got it, say, a product for free from Novo Nordisk, or you bought it at say a cash program, the insurance company would not count that against your deductible
The earliest Ozempic lawsuits focused on stomach paralysis (gastroparesis) and intestinal blockages (ileus)
doi: 10.2337/dci23-0100 18 DashS